Evidence map›Paper›PMID 25386959›Full record

ArticleTranslational psychiatry2014

Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation.

J L Johnson, P E Rolan, M E Johnson, L Bobrovskaya, D B Williams, K Johnson, J Tuke, M R Hutchinson

Open access · goldAbstract readComparative Study
In one paragraph

Article in Translational psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Review
  3. Mu-Opioid Receptor (MOR) Dependence of Pain in Chemotherapy-Induced Peripheral Neuropathy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

J L JohnsonDiscipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
P E Rolan1] Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, SA, Australia [2] Pain and Anaesthesia Research Clinic, University of Adelaide, Adelaide, SA, Australia [3] Pain Management Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.
M E JohnsonSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
L BobrovskayaSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
D B WilliamsSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
K JohnsonMedicinova, San Diego, CA, USA.
J TukeSchool of Mathematical Sciences, University of Adelaide, Adelaide, SA, Australia.
M R HutchinsonDiscipline of Physiology, School of Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
University of Adelaide · AUUniversity of South Australia · AUMediciNova (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic morphine therapy has been associated with paradoxically increased pain. Codeine is a widely used opioid, which is metabolized to morphine to elicit analgesia. Prolonged morphine exposure exacerbates pain by activating the innate immune toll-like receptor-4 (TLR4) in the central nervous system. In silico docking simulations indicate codeine also docks to MD2, an accessory protein for TLR4, suggesting potential to induce TLR4-dependent pain facilitation. We hypothesized codeine would cause TLR4-dependent hyperalgesia/allodynia that is disparate from its opioid receptor-dependent analgesic rank potency. Hyperalgesia and allodynia were assessed using hotplate and von Frey tests at days 0, 3 and 5 in mice receiving intraperitoneal equimolar codeine (21 mg kg(-1)), morphine (20 mg kg(-1)) or saline, twice daily. This experiment was repeated in animals with prior partial nerve injury and in TLR4 null mutant mice. Interventions with interleukin-1 receptor antagonist (IL-1RA) and glial-attenuating drug ibudilast were assessed. Analyses of glial activation markers (glial fibrillary acid protein and CD11b) in neuronal tissue were conducted at the completion of behavioural testing. Despite providing less acute analgesia (P=0.006), codeine induced similar hotplate hyperalgesia to equimolar morphine vs saline (-9.5 s, P<0.01 and -7.3 s, P<0.01, respectively), suggesting codeine does not rely upon conversion to morphine to increase pain sensitivity. This highlights the potential non-opioid receptor-dependent nature of codeine-enhanced pain sensitivity-although the involvement of other codeine metabolites cannot be ruled out. IL-1RA reversed codeine-induced hyperalgesia (P<0.001) and allodynia (P<0.001), and TLR4 knock-out protected against codeine-induced changes in pain sensitivity. Glial attenuation with ibudilast reversed codeine-induced allodynia (P<0.001), and thus could be investigated further as potential treatment for codeine-induced pain enhancement.

Indexed as

Analgesics, OpioidAnimalsBehavior, AnimalCodeineHyperalgesiaInterleukin 1 Receptor Antagonist ProteinMiceMice, Inbred BALB CMice, KnockoutMorphineNeurogliaPain ThresholdRandom AllocationSciatic NerveToll-Like Receptor 4Analgesics, OpioidCodeineIl1rn protein, mouseInterleukin 1 Receptor Antagonist ProteinMorphineTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID25386959
PMCPMC4259992
OpenAlexW2013349444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.